The Business Research Company’s ColorectalCancer Drugs Global Market Report 2019 covers market characteristics, size and
growth, segmentation, regional and country breakdowns, competitive landscape,
market shares, trends and strategies for this market. It traces the market’s
historic and forecast market growth by geography.
The colorectal cancer drugs market consists
of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is
the cancer affecting large intestine and the rectum. They are also named, colon
tumor or rectal cancer depending upon where they begin.
Read Full
Report @ https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
North America was the largest region in the
colorectal cancer drugs market in 2018. This region is expected to remain the
largest during the next five years. The colorectal cancer drugs market in Asia
Pacific is forecasted to register the highest CAGR during 2018-2023.
The number of colorectal cancer worldwide has
been increasing. According to the American Cancer Society (ACS) estimates,
there will be around 101,420 new cases of colon cancer and around 44,180 new
cases of rectal cancer that would be registered in the USA in 2019. The
diagnosed incident cases of colorectal cancer are expected to increase by 27.3%
to 672,400 cases by 2037. The reason for this increase can be attributed to
factors such as low-fiber diet, obesity, consumption of alcohol and tobacco
amongst others. The increase in number of colorectal cases will add to the
overall size of the global colorectal cancer drugs market.
Major players in the market are Merck & Co. Inc, Roche, Sanofi, Amgen,
PFIZER, INC.
Request a SAMPLE of
This Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smp
About The Business Research Company:
The Business Research Company is a
Business Intelligence Company which excels in company, market and consumer
research. It has offices in the UK, the US and India and a network of trained
researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
